Karen Caroll's practice focuses on complex intellectual property litigation and counseling, with a specific focus on pharmaceutical and biotechnology-related patent matters, including Hatch-Waxman litigation. Additionally, she has handled matters involving technologies outside of the biopharmaceutical industry, including in the areas of mechanical devices, computer and computer software devices, telecommunications, and medical devices.
Karen also provides a range of counseling services to her clients, including due diligence and freedom-to-operate analyses, patent valuations, and licensing advice. She counsels pharmaceutical clients on transactional matters pertaining to commercial supply chain contracts, wholesale distribution agreements, and product offers.
Prior to her legal career, Karen worked for more than 10 years in the biopharmaceutical industry, first as a research scientist at the Department of Neuropathology at Johns Hopkins University and Codon Pharmaceuticals, and then as a patent agent at Human Genome Sciences Inc. During her time as a patent agent, she procured a wide array of patents worldwide covering genes, proteins, antibodies, and methods of diagnosing and treating patients, as well as small-molecule pharmaceutical products and formulations. In addition to her patent prosecuting experience, Karen advised members of the scientific staff on a variety of matters relating to patent, regulatory, and Hatch-Waxman issues.